Structure

Physi-Chem Properties

Molecular Weight:  536.23
Volume:  510.356
LogP:  2.02
LogD:  1.936
LogS:  -4.131
# Rotatable Bonds:  11
TPSA:  153.37
# H-Bond Aceptor:  11
# H-Bond Donor:  4
# Rings:  8
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.244
Synthetic Accessibility Score:  6.258
Fsp3:  0.741
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.983
MDCK Permeability:  2.491716804797761e-05
Pgp-inhibitor:  0.051
Pgp-substrate:  0.978
Human Intestinal Absorption (HIA):  0.45
20% Bioavailability (F20%):  0.273
30% Bioavailability (F30%):  0.637

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.117
Plasma Protein Binding (PPB):  69.30094146728516%
Volume Distribution (VD):  0.859
Pgp-substrate:  8.747713088989258%

ADMET: Metabolism

CYP1A2-inhibitor:  0.01
CYP1A2-substrate:  0.99
CYP2C19-inhibitor:  0.018
CYP2C19-substrate:  0.64
CYP2C9-inhibitor:  0.02
CYP2C9-substrate:  0.016
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.058
CYP3A4-inhibitor:  0.575
CYP3A4-substrate:  0.21

ADMET: Excretion

Clearance (CL):  6.377
Half-life (T1/2):  0.747

ADMET: Toxicity

hERG Blockers:  0.043
Human Hepatotoxicity (H-HT):  0.068
Drug-inuced Liver Injury (DILI):  0.13
AMES Toxicity:  0.962
Rat Oral Acute Toxicity:  0.098
Maximum Recommended Daily Dose:  0.072
Skin Sensitization:  0.916
Carcinogencity:  0.932
Eye Corrosion:  0.003
Eye Irritation:  0.021
Respiratory Toxicity:  0.93

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469415

Natural Product ID:  NPC469415
Common Name*:   WZGDJBIFNLWZEF-POZPPLBNSA-N
IUPAC Name:   n.a.
Synonyms:   4-O-Butylpaeoniflorin
Standard InCHIKey:  WZGDJBIFNLWZEF-POZPPLBNSA-N
Standard InCHI:  InChI=1S/C27H36O11/c1-3-4-10-34-26-13-24(2)27(36-22-20(31)19(30)18(29)16(12-28)35-22)11-17(26)25(27,23(37-24)38-26)14-33-21(32)15-8-6-5-7-9-15/h5-9,16-20,22-23,28-31H,3-4,10-14H2,1-2H3/t16-,17+,18-,19+,20-,22+,23?,24+,25+,26-,27-/m1/s1
SMILES:  CCCCOC12CC3(C4(CC1C4(C(O3)O2)COC(=O)C5=CC=CC=C5)OC6C(C(C(C(O6)CO)O)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1078184
PubChem CID:   44253994
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota n.a. n.a. n.a. PMID[11339628]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota n.a. bark n.a. PMID[17260795]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota n.a. Daejeon, Korea 2007-Jan PMID[19670875]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota n.a. seed n.a. PMID[20822014]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota n.a. root n.a. PMID[22547314]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota root bark Bozhou, Anhui Province, China 2010-AUG PMID[24377852]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota n.a. flower n.a. PMID[24504864]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota Flowers LuoYang, HeNan, China n.a. PMID[24621197]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO22550 Paeonia suffruticosa Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 > 100000.0 nM PMID[553486]
NPT68 Individual Protein Aldose reductase Rattus norvegicus IC50 = 36200.0 nM PMID[553485]
NPT35 Others n.a. IC50 = 10800.0 nM PMID[553485]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469415 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9929 High Similarity NPC222102
0.9929 High Similarity NPC303429
0.9792 High Similarity NPC469398
0.9792 High Similarity NPC469422
0.9655 High Similarity NPC34066
0.9527 High Similarity NPC477623
0.9379 High Similarity NPC469448
0.932 High Similarity NPC133430
0.932 High Similarity NPC469477
0.9257 High Similarity NPC5115
0.92 High Similarity NPC469399
0.915 High Similarity NPC293568
0.915 High Similarity NPC117943
0.9091 High Similarity NPC472576
0.9091 High Similarity NPC87448
0.9091 High Similarity NPC291599
0.9091 High Similarity NPC118080
0.9091 High Similarity NPC27377
0.9091 High Similarity NPC97947
0.9091 High Similarity NPC41481
0.9038 High Similarity NPC469459
0.9032 High Similarity NPC120012
0.9021 High Similarity NPC97667
0.9021 High Similarity NPC90614
0.9021 High Similarity NPC100913
0.9021 High Similarity NPC275592
0.9021 High Similarity NPC171207
0.9007 High Similarity NPC469417
0.8974 High Similarity NPC265600
0.8958 High Similarity NPC16912
0.8917 High Similarity NPC149002
0.8917 High Similarity NPC469458
0.8917 High Similarity NPC469396
0.8917 High Similarity NPC88176
0.8904 High Similarity NPC241951
0.8904 High Similarity NPC470152
0.8904 High Similarity NPC475759
0.8889 High Similarity NPC472547
0.8868 High Similarity NPC469421
0.8859 High Similarity NPC476173
0.8854 High Similarity NPC469420
0.8844 High Similarity NPC470159
0.8844 High Similarity NPC70403
0.8844 High Similarity NPC472568
0.8844 High Similarity NPC96903
0.8844 High Similarity NPC471104
0.8844 High Similarity NPC469349
0.8844 High Similarity NPC29704
0.8844 High Similarity NPC174982
0.8844 High Similarity NPC177940
0.8844 High Similarity NPC472572
0.8844 High Similarity NPC473088
0.8844 High Similarity NPC158663
0.8844 High Similarity NPC171525
0.8844 High Similarity NPC476973
0.8844 High Similarity NPC184817
0.8844 High Similarity NPC472571
0.8844 High Similarity NPC200471
0.8844 High Similarity NPC472575
0.8844 High Similarity NPC470157
0.8836 High Similarity NPC163087
0.8812 High Similarity NPC477617
0.8808 High Similarity NPC471135
0.8808 High Similarity NPC472657
0.8808 High Similarity NPC472658
0.8784 High Similarity NPC469513
0.8784 High Similarity NPC478263
0.8776 High Similarity NPC57628
0.8776 High Similarity NPC11685
0.8776 High Similarity NPC70716
0.8776 High Similarity NPC95265
0.8776 High Similarity NPC125106
0.8776 High Similarity NPC95810
0.8776 High Similarity NPC472573
0.8776 High Similarity NPC188865
0.8776 High Similarity NPC38696
0.8776 High Similarity NPC476974
0.8776 High Similarity NPC472570
0.8776 High Similarity NPC472569
0.8776 High Similarity NPC25768
0.8776 High Similarity NPC163719
0.8776 High Similarity NPC475122
0.8767 High Similarity NPC34012
0.875 High Similarity NPC469456
0.875 High Similarity NPC39549
0.8741 High Similarity NPC472577
0.8741 High Similarity NPC291638
0.8741 High Similarity NPC17877
0.8741 High Similarity NPC195647
0.8741 High Similarity NPC66761
0.8716 High Similarity NPC478264
0.8707 High Similarity NPC91703
0.8701 High Similarity NPC476784
0.8696 High Similarity NPC148185
0.8693 High Similarity NPC475548
0.8693 High Similarity NPC290683
0.8693 High Similarity NPC475638
0.8681 High Similarity NPC472551
0.8681 High Similarity NPC472545
0.8671 High Similarity NPC474608
0.8667 High Similarity NPC301556
0.8667 High Similarity NPC476975
0.8667 High Similarity NPC270590
0.8667 High Similarity NPC92293
0.8667 High Similarity NPC471101
0.8667 High Similarity NPC266265
0.8658 High Similarity NPC474935
0.8658 High Similarity NPC240115
0.865 High Similarity NPC469397
0.8636 High Similarity NPC318447
0.8636 High Similarity NPC322048
0.8611 High Similarity NPC473216
0.8611 High Similarity NPC473399
0.8609 High Similarity NPC470245
0.8609 High Similarity NPC473214
0.8608 High Similarity NPC473557
0.8608 High Similarity NPC473468
0.8608 High Similarity NPC475567
0.8608 High Similarity NPC477491
0.86 High Similarity NPC281717
0.86 High Similarity NPC217918
0.8598 High Similarity NPC80360
0.8591 High Similarity NPC92867
0.8591 High Similarity NPC472556
0.8591 High Similarity NPC311825
0.8571 High Similarity NPC323001
0.8571 High Similarity NPC326235
0.8553 High Similarity NPC471103
0.8553 High Similarity NPC475198
0.8553 High Similarity NPC470153
0.8553 High Similarity NPC475531
0.8553 High Similarity NPC475175
0.8545 High Similarity NPC195114
0.8544 High Similarity NPC477627
0.8544 High Similarity NPC471493
0.8543 High Similarity NPC473215
0.8533 High Similarity NPC20255
0.8526 High Similarity NPC326328
0.8526 High Similarity NPC323356
0.8526 High Similarity NPC309991
0.8526 High Similarity NPC471138
0.8523 High Similarity NPC34943
0.8514 High Similarity NPC472546
0.8506 High Similarity NPC469730
0.8506 High Similarity NPC473632
0.8506 High Similarity NPC132599
0.8503 High Similarity NPC4341
0.8503 High Similarity NPC473085
0.8503 High Similarity NPC48017
0.8503 High Similarity NPC184747
0.8503 High Similarity NPC476094
0.8503 High Similarity NPC473081
0.8503 High Similarity NPC477904
0.8503 High Similarity NPC43241
0.8503 High Similarity NPC473613
0.8503 High Similarity NPC473758
0.8503 High Similarity NPC211137
0.8503 High Similarity NPC473060
0.8503 High Similarity NPC473112
0.8503 High Similarity NPC200592
0.8503 High Similarity NPC147880
0.8503 High Similarity NPC183270
0.8503 High Similarity NPC473109
0.85 High Similarity NPC102465
0.8497 Intermediate Similarity NPC472548
0.8497 Intermediate Similarity NPC477905
0.8494 Intermediate Similarity NPC188217
0.8493 Intermediate Similarity NPC183122
0.8493 Intermediate Similarity NPC283375
0.8487 Intermediate Similarity NPC91730
0.8485 Intermediate Similarity NPC260300
0.8481 Intermediate Similarity NPC329960
0.8481 Intermediate Similarity NPC295408
0.8481 Intermediate Similarity NPC150893
0.8477 Intermediate Similarity NPC473760
0.8476 Intermediate Similarity NPC469438
0.8467 Intermediate Similarity NPC125882
0.8462 Intermediate Similarity NPC319404
0.8456 Intermediate Similarity NPC477894
0.8447 Intermediate Similarity NPC477488
0.8447 Intermediate Similarity NPC477471
0.8447 Intermediate Similarity NPC477469
0.8447 Intermediate Similarity NPC469419
0.8447 Intermediate Similarity NPC477473
0.8447 Intermediate Similarity NPC477466
0.8446 Intermediate Similarity NPC77493
0.8446 Intermediate Similarity NPC224491
0.8435 Intermediate Similarity NPC214550
0.8435 Intermediate Similarity NPC210591
0.8435 Intermediate Similarity NPC475652
0.8431 Intermediate Similarity NPC197037
0.8431 Intermediate Similarity NPC51602
0.8418 Intermediate Similarity NPC43304
0.8418 Intermediate Similarity NPC477190
0.8418 Intermediate Similarity NPC477188
0.8418 Intermediate Similarity NPC478124
0.8411 Intermediate Similarity NPC477737
0.8411 Intermediate Similarity NPC48599
0.8411 Intermediate Similarity NPC209592
0.8411 Intermediate Similarity NPC473602

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469415 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8232 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD7799 Discontinued
0.7836 Intermediate Similarity NPD8407 Phase 2
0.777 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD8368 Discontinued
0.7532 Intermediate Similarity NPD7236 Approved
0.7529 Intermediate Similarity NPD7228 Approved
0.75 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7443 Intermediate Similarity NPD8434 Phase 2
0.741 Intermediate Similarity NPD4967 Phase 2
0.741 Intermediate Similarity NPD4965 Approved
0.741 Intermediate Similarity NPD4966 Approved
0.7407 Intermediate Similarity NPD7239 Suspended
0.7386 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD8361 Approved
0.736 Intermediate Similarity NPD8435 Approved
0.736 Intermediate Similarity NPD8360 Approved
0.7356 Intermediate Similarity NPD7240 Approved
0.7329 Intermediate Similarity NPD5126 Approved
0.7329 Intermediate Similarity NPD5125 Phase 3
0.7321 Intermediate Similarity NPD6234 Discontinued
0.7247 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD37 Approved
0.7222 Intermediate Similarity NPD8389 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD7266 Discontinued
0.7182 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD8313 Approved
0.7175 Intermediate Similarity NPD8312 Approved
0.7159 Intermediate Similarity NPD6559 Discontinued
0.7097 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD8455 Phase 2
0.7081 Intermediate Similarity NPD4628 Phase 3
0.7062 Intermediate Similarity NPD7685 Pre-registration
0.7034 Intermediate Similarity NPD2629 Approved
0.7 Intermediate Similarity NPD7057 Phase 3
0.7 Intermediate Similarity NPD7058 Phase 2
0.6993 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6959 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6949 Remote Similarity NPD7074 Phase 3
0.6946 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6946 Remote Similarity NPD7458 Discontinued
0.6936 Remote Similarity NPD8127 Discontinued
0.6936 Remote Similarity NPD7199 Phase 2
0.6935 Remote Similarity NPD8485 Approved
0.6932 Remote Similarity NPD3818 Discontinued
0.6898 Remote Similarity NPD7699 Phase 2
0.6898 Remote Similarity NPD7700 Phase 2
0.6893 Remote Similarity NPD5844 Phase 1
0.6893 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6893 Remote Similarity NPD7054 Approved
0.6872 Remote Similarity NPD8462 Phase 1
0.6871 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6871 Remote Similarity NPD4198 Discontinued
0.6868 Remote Similarity NPD8150 Discontinued
0.6859 Remote Similarity NPD8320 Phase 1
0.6859 Remote Similarity NPD8319 Approved
0.6859 Remote Similarity NPD7008 Discontinued
0.6854 Remote Similarity NPD7472 Approved
0.6848 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6846 Remote Similarity NPD7741 Discontinued
0.6829 Remote Similarity NPD6190 Approved
0.6828 Remote Similarity NPD6534 Approved
0.6828 Remote Similarity NPD6535 Approved
0.6828 Remote Similarity NPD969 Suspended
0.6826 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6815 Remote Similarity NPD3764 Approved
0.6806 Remote Similarity NPD7435 Discontinued
0.6784 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6784 Remote Similarity NPD7819 Suspended
0.6783 Remote Similarity NPD6686 Approved
0.6778 Remote Similarity NPD7251 Discontinued
0.6772 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6768 Remote Similarity NPD8166 Discontinued
0.6766 Remote Similarity NPD6273 Approved
0.6763 Remote Similarity NPD7075 Discontinued
0.6761 Remote Similarity NPD7184 Clinical (unspecified phase)
0.674 Remote Similarity NPD7808 Phase 3
0.674 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6736 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6736 Remote Similarity NPD2182 Approved
0.6727 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6722 Remote Similarity NPD6797 Phase 2
0.6719 Remote Similarity NPD7497 Discontinued
0.6719 Remote Similarity NPD7680 Approved
0.6711 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6706 Remote Similarity NPD7028 Phase 2
0.6706 Remote Similarity NPD4380 Phase 2
0.6705 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6703 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6689 Remote Similarity NPD5951 Approved
0.6686 Remote Similarity NPD5761 Phase 2
0.6686 Remote Similarity NPD1653 Approved
0.6686 Remote Similarity NPD5760 Phase 2
0.6686 Remote Similarity NPD5494 Approved
0.6685 Remote Similarity NPD6764 Approved
0.6685 Remote Similarity NPD6765 Approved
0.6667 Remote Similarity NPD7516 Approved
0.6667 Remote Similarity NPD6823 Phase 2
0.6667 Remote Similarity NPD7961 Discontinued
0.665 Remote Similarity NPD8404 Phase 2
0.6649 Remote Similarity NPD6782 Approved
0.6649 Remote Similarity NPD6778 Approved
0.6649 Remote Similarity NPD6777 Approved
0.6649 Remote Similarity NPD6781 Approved
0.6649 Remote Similarity NPD6780 Approved
0.6649 Remote Similarity NPD6779 Approved
0.6649 Remote Similarity NPD6776 Approved
0.6649 Remote Similarity NPD7999 Approved
0.6645 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6644 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6632 Remote Similarity NPD7698 Approved
0.6632 Remote Similarity NPD7697 Approved
0.6632 Remote Similarity NPD7696 Phase 3
0.6629 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6623 Remote Similarity NPD7507 Approved
0.6608 Remote Similarity NPD6599 Discontinued
0.6607 Remote Similarity NPD2532 Approved
0.6607 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6607 Remote Similarity NPD2533 Approved
0.6607 Remote Similarity NPD2534 Approved
0.6606 Remote Similarity NPD6674 Discontinued
0.6603 Remote Similarity NPD7319 Approved
0.66 Remote Similarity NPD7328 Approved
0.66 Remote Similarity NPD7327 Approved
0.6599 Remote Similarity NPD7874 Approved
0.6599 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6592 Remote Similarity NPD7473 Discontinued
0.6585 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6585 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6585 Remote Similarity NPD6004 Phase 3
0.6585 Remote Similarity NPD6002 Phase 3
0.6585 Remote Similarity NPD6005 Phase 3
0.6585 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6584 Remote Similarity NPD230 Phase 1
0.6582 Remote Similarity NPD7701 Phase 2
0.6577 Remote Similarity NPD690 Clinical (unspecified phase)
0.6562 Remote Similarity NPD6663 Approved
0.6552 Remote Similarity NPD5402 Approved
0.655 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6548 Remote Similarity NPD8151 Discontinued
0.6541 Remote Similarity NPD6785 Approved
0.6541 Remote Similarity NPD6784 Approved
0.6532 Remote Similarity NPD6801 Discontinued
0.6517 Remote Similarity NPD6232 Discontinued
0.6513 Remote Similarity NPD7871 Phase 2
0.6513 Remote Similarity NPD7870 Phase 2
0.6508 Remote Similarity NPD6213 Phase 3
0.6508 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6508 Remote Similarity NPD6212 Phase 3
0.6503 Remote Similarity NPD7097 Phase 1
0.6494 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6486 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6485 Remote Similarity NPD2346 Discontinued
0.6482 Remote Similarity NPD7783 Phase 2
0.6482 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6482 Remote Similarity NPD7801 Approved
0.6481 Remote Similarity NPD6355 Discontinued
0.6471 Remote Similarity NPD8513 Phase 3
0.6471 Remote Similarity NPD8516 Approved
0.6471 Remote Similarity NPD8378 Approved
0.6471 Remote Similarity NPD8296 Approved
0.6471 Remote Similarity NPD8379 Approved
0.6471 Remote Similarity NPD8517 Approved
0.6471 Remote Similarity NPD7503 Approved
0.6471 Remote Similarity NPD8380 Approved
0.6471 Remote Similarity NPD8033 Approved
0.6471 Remote Similarity NPD8335 Approved
0.6471 Remote Similarity NPD8515 Approved
0.6468 Remote Similarity NPD7930 Approved
0.6467 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6467 Remote Similarity NPD7003 Approved
0.6464 Remote Similarity NPD3751 Discontinued
0.6458 Remote Similarity NPD164 Approved
0.6457 Remote Similarity NPD3817 Phase 2
0.6452 Remote Similarity NPD6287 Discontinued
0.6448 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6444 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6444 Remote Similarity NPD6166 Phase 2
0.6444 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6437 Remote Similarity NPD1934 Approved
0.6433 Remote Similarity NPD5403 Approved
0.6429 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6425 Remote Similarity NPD3787 Discontinued
0.6424 Remote Similarity NPD2935 Discontinued
0.6415 Remote Similarity NPD5736 Approved
0.6412 Remote Similarity NPD5401 Approved
0.6407 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6405 Remote Similarity NPD9545 Approved
0.6405 Remote Similarity NPD8294 Approved
0.6405 Remote Similarity NPD8377 Approved
0.64 Remote Similarity NPD1465 Phase 2
0.64 Remote Similarity NPD6010 Discontinued
0.6389 Remote Similarity NPD6647 Phase 2
0.6386 Remote Similarity NPD5763 Approved
0.6386 Remote Similarity NPD5762 Approved
0.6386 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6379 Remote Similarity NPD7411 Suspended
0.6374 Remote Similarity NPD7314 Clinical (unspecified phase)
0.637 Remote Similarity NPD6685 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data